Literature DB >> 26913711

First reported use of elvitegravir and cobicistat during pregnancy.

Stein Schalkwijk1, Angela Colbers, Deborah Konopnicki, Rick Greupink, Frans G M Russel, David Burger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26913711     DOI： 10.1097/QAD.0000000000000976

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  10 in total

1.  Free and total plasma concentrations of elvitegravir/cobicistat during pregnancy and postpartum: a case report.

Authors:  Catia Marzolini; Laurent Decosterd; Ursula Winterfeld; Frédéric Tissot; Katyuska Francini; Thierry Buclin; Françoise Livio
Journal:  Br J Clin Pharmacol       Date:  2017-05-16       Impact factor: 4.335

Review 2.  Beyond one pill, once daily: current challenges of antiretroviral therapy management in the United States.

Authors:  Mary Clare Masters; Karen M Krueger; Janna L Williams; Lindsay Morrison; Susan E Cohn
Journal:  Expert Rev Clin Pharmacol       Date:  2019-12       Impact factor: 5.045

3.  Elvitegravir/cobicistat pharmacokinetics in pregnant and postpartum women with HIV.

Authors:  Jeremiah D Momper; Brookie M Best; Jiajia Wang; Edmund V Capparelli; Alice Stek; Emily Barr; Martina L Badell; Edward P Acosta; Murli Purswani; Elizabeth Smith; Nahida Chakhtoura; Kyunghun Park; Sandra Burchett; David E Shapiro; Mark Mirochnick
Journal:  AIDS       Date:  2018-11-13       Impact factor: 4.177

Review 4.  Pharmacokinetic Enhancement of HIV Antiretroviral Therapy During Pregnancy.

Authors:  Engie Salama; Ahizechukwu C Eke; Brookie M Best; Mark Mirochnick; Jeremiah D Momper
Journal:  J Clin Pharmacol       Date:  2020-08-14       Impact factor: 3.126

Review 5.  Drug-Drug Interactions with Antiretroviral Drugs in Pregnant Women Living with HIV: Are They Different from Non-Pregnant Individuals?

Authors:  Vera E Bukkems; Angela Colbers; Catia Marzolini; Jose Molto; David M Burger
Journal:  Clin Pharmacokinet       Date:  2020-10       Impact factor: 6.447

Review 6.  Comparative Clinical Pharmacokinetics and Pharmacodynamics of HIV-1 Integrase Strand Transfer Inhibitors.

Authors:  Anthony T Podany; Kimberly K Scarsi; Courtney V Fletcher
Journal:  Clin Pharmacokinet       Date:  2017-01       Impact factor: 6.447

Review 7.  Tenofovir alafenamide use in pregnant and lactating women living with HIV.

Authors:  Ahizechukwu C Eke; Kristina M Brooks; Rahel D Gebreyohannes; Jeanne S Sheffield; Kelly E Dooley; Mark Mirochnick
Journal:  Expert Opin Drug Metab Toxicol       Date:  2020-03-17       Impact factor: 4.936

8.  A Multicenter Analysis of Elvitegravir Use During Pregnancy on HIV Viral Suppression and Perinatal Outcomes.

Authors:  Martina L Badell; Anandi N Sheth; Florence Momplaisir; Lisa Rahangdale; JoNell Potter; Padmashree C Woodham; Gweneth B Lazenby; William R Short; Scott E Gillespie; Nevert Baldreldin; Emily S Miller; Gregg Alleyne; Lunthita M Duthely; Stephanie M Allen; Judy Levison; Rana Chakraborty
Journal:  Open Forum Infect Dis       Date:  2019-03-18       Impact factor: 3.835

Review 9.  Pharmacokinetics of HIV-Integrase Inhibitors During Pregnancy: Mechanisms, Clinical Implications and Knowledge Gaps.

Authors:  Ruben van der Galiën; Rob Ter Heine; Rick Greupink; Stein J Schalkwijk; Antonius E van Herwaarden; Angela Colbers; David M Burger
Journal:  Clin Pharmacokinet       Date:  2019-03       Impact factor: 6.447

Review 10.  HIV-1 Integrase Inhibitors: A Comparative Review of Efficacy and Safety.

Authors:  Kimberly K Scarsi; Joshua P Havens; Anthony T Podany; Sean N Avedissian; Courtney V Fletcher
Journal:  Drugs       Date:  2020-11       Impact factor: 9.546
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.